C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2004
12/02/2004	US20040242642 Crystalline esomeprazole compounds and process for the preparation thereof
12/02/2004	US20040242639 Compounds such as 4-[4-(2-methoxyphenyl)-1-piperazinyl]-3-[[(phenylamino)carbonyl]amino]-benzamide, for therapy of restenosis
12/02/2004	US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity
12/02/2004	US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004	US20040242632 Method for treating inflammatory bowel disease
12/02/2004	US20040242628 administering N-(1H-Indol-7-yl)-4-nitrobenzenesulfonamide; treating cachexia during cancer therapy
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242619 Processes for preparation of polymorphic forms of desloratadine
12/02/2004	US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia
12/02/2004	US20040242613 Pyrimidine derivatives useful as inhibitors of PKC-theta
12/02/2004	US20040242611 Novel phenylamino-pyrimidines and uses thereof
12/02/2004	US20040242609 Therapy for eating disorders, sexual disorders, psychological disorders
12/02/2004	US20040242608 Substituted pyrimidinones
12/02/2004	US20040242604 Substituted heterocycles for the treatment of abnormal cell growth
12/02/2004	US20040242603 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same
12/02/2004	US20040242601 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
12/02/2004	US20040242589 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
12/02/2004	US20040242581 potent inhibitors of factor Xa which may have high bioavailability following oral administration
12/02/2004	US20040242580 can be applied as sprays by methods commonly employed in crops such as vegetables, fruits, ornamentals, seeds, turf, cereal and vines among other plants
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
12/02/2004	US20040242568 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242567 alone or in combination with a diuretic agent; diabetic nephropathy
12/02/2004	US20040242566 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives
12/02/2004	US20040242559 Novel indole derivatives, preparation thereof as medicinal products and pharmaceutical compositions, and especially as KDR inhibitors
12/02/2004	US20040242558 Pyridylether derivatives, their preparation and use
12/02/2004	US20040242554 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants
12/02/2004	US20040242498 CXCR3 antagonists
12/02/2004	US20040242493 Neurotensin active 2,3,diaryl-pyrazolidine derivatives
12/02/2004	US20040242492 Mandelic acid derivatives and their use as thrombin inhibitors
12/02/2004	US20040241781 Using benzodiazepine derivatives to treat and prevent defects in programed cell death, autoimmune, inflammatory and cell proliferative diseases
12/02/2004	US20040239739 Novel anthrapyridone compounds, water-base magenta ink compositions, and ink-jet recording process
12/02/2004	DE10309929A1 Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung Benzoylureidopyridyl substituted-piperidine and -pyrrolidine carboxylic acid derivatives, processes for their preparation and their use
12/02/2004	CA2526374A1 2-aminoquinoline derivatives
12/02/2004	CA2525292A1 Phenyl quinolines and their use as estrogenic agents
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1481972A1 Cyclic compound, process for producing the same, and pest control agent
12/01/2004	EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
12/01/2004	EP1481966A1 Novel arylamidine derivative or salt thereof
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1480974A1 Heterocyclylmethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
12/01/2004	EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004	EP1480972A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/01/2004	EP1480971A1 Isoquinoline derivatives
12/01/2004	EP1480970A1 Quinoline derivatives
12/01/2004	EP1480958A1 Uracil-thioether
12/01/2004	EP1480957A1 Hppars activators
12/01/2004	EP1480954A1 Vanilloid receptor modulators
12/01/2004	EP1480944A2 Substituted aryl ketones
12/01/2004	EP1480688A1 N-(5- 4-(4-methyl-piperazino-methyl)-benzoylamido)-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine coated stents
12/01/2004	EP1480643A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
12/01/2004	EP1480628A1 Use of sodium/hydrogen exchange inhibitors for the treatment of thrombotic and inflammatory diseases
12/01/2004	EP1358180B1 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
12/01/2004	EP1351991A4 Ternary biomolecule/polymer/surface-based immobilization systems
12/01/2004	EP1318996B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/01/2004	EP1175408B1 Pyrimidinone compounds
12/01/2004	EP1156037B1 Chondrongenesis promotors and indolin-2-one derivatives
12/01/2004	EP1104407B1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0886637B1 Inhibitors of microsomal triglyceride transfer protein and method
12/01/2004	CN1551878A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/01/2004	CN1551877A Piperidine derivatives useful as CCR5 antagonists
12/01/2004	CN1551876A 6-aryl-4-aminopicolinates and their use as herbicides
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1551768A Substituted benzimidazole dosage forms and method of using same
12/01/2004	CN1550498A Substituted guanidine derivatives
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1177844C Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/01/2004	CN1177832C Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
12/01/2004	CN1177821C Matrix metalloprotease inhibitors
11/2004
11/30/2004	US6825356 Catalysts containing N-pyrrolyl substituted nitrogen donors
11/30/2004	US6825353 Process for producing quinolonecarboxylic acids and intermediates thereof
11/30/2004	US6825245 Solvent-free; controlling viscosity; material handling
11/30/2004	US6825228 To treat infections by gram-positive bacteria, in particular drug- resistant strains
11/30/2004	US6825220 3-Substituted oxindole β 3 agonists
11/30/2004	US6825219 Substituted benzimidazole compounds
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825215 1,1-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-α
11/30/2004	US6825214 Substantially pure cilostazol and processes for making same
11/30/2004	US6825204 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825191 Benzodiazepine derivatives
11/30/2004	US6825189 Treating withdrawal symptoms caused by smoking cessation
11/30/2004	US6825188 More potent inhibitors of the vitronectin receptor than the fibrinogen
11/30/2004	US6825181 Orally administrated to exhibit a strong anticoagulant effect by inhibiting activated blood- coagulation factor x
11/30/2004	US6825043 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
11/30/2004	CA2362117C A system for cell-based screening
11/25/2004	WO2004101559A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2004	WO2004101556A1 INDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004	WO2004101553A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004	WO2004101549A1 2-anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors
11/25/2004	WO2004101546A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
11/25/2004	WO2004101544A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	WO2004101533A1 1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands
11/25/2004	WO2004101532A1 Substituted triazolecarboxamides
11/25/2004	WO2004101528A2 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004	WO2004101522A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof

1 ... 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 ... 1080